Riskpilot← Back to searchSign inGet full accessPhillips-Medisize Holdings A/S
A/SActiveCVR 37705497Gimsinglundvej 20Industrial product and fashion design activities · NACE 7411Est. 2016— employees
Revenue 2024
DKK 0
EBITDA margin
—
-38% vs 2023
Equity ratio
23.4%
Financial strength
Net profit 2024
DKK 118,3M
+1440% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -271K | -38% |
| Net profit | DKK 118,3M | +1440% |
| Total assets | DKK 288M | +32% |
| Equity | DKK 67,3M | +232% |
| Employees | — | — |
Legal name
Phillips-Medisize Holdings A/S
CVR number
37705497
Legal form
Aktieselskab
NACE code
7411 · Industrial product and fashion design activities
Founded
23. maj 2016
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af den samlede bestyrelse, af bestyrelsesformanden i forening med en direktør eller af to medlemmer af bestyrelsen i forening med en direktør.
Company purpose
Virksomhedens formål er at drive virksomhed med rådgivning, design, udvikling og fremstilling af udstyr og applikationer til indgivelse af lægemidler og diagnosticering samt forbrugsartikler samt anden virksomhed, der efter bestyrelsens skøn er i naturlig tilknytning hertil, enten direkte eller ved kapitalanbringelse i andre selskaber.
Address
Gimsinglundvej 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | — | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -216 | -86 | -42 | -197 | -271 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -216 | -86 | -42 | -197 | -271 |
| Net financials | 11.468 | -21.278 | -19.499 | -9.896 | -28.113 |
| Profit before tax | 11.252 | -21.364 | -19.541 | -10.093 | 111.616 |
| Tax | 2.475 | -3.892 | -1.527 | -1.264 | -6.712 |
| Net profit | 8.777 | -17.472 | -18.014 | -8.829 | 118.328 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 190.970 | 208.682 | 214.232 | 218.299 | 287.971 |
| Equity | -6.703 | -24.175 | -42.189 | -51.018 | 67.310 |
| Long-term debt | 189.486 | 201.395 | 215.078 | 189.344 | 220.285 |
| Short-term debt | 8.187 | 31.462 | 41.343 | 79.095 | 376 |
| Total debt | 197.673 | 232.857 | 256.421 | 268.439 | 220.661 |
EBITDA margin
-27100000.0%
This company
15.8%
Market median
-171519087% vs market
20202024
Equity ratio
23.4%
This company
38.2%
Market median
-39% vs market
20202024
Return on equity
175.8%
This company
18.4%
Market median
+855% vs market
20202024
Net profit margin
11832800000.0%
This company
8.1%
Market median
+146083950517% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
3.28×
This company
0.62×
Market median
-429% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CR Chief Executive Officer | Chief Executive Officer | 2024 |
MB Founder | Founder | 2016 |
| Former (4) | ||
JC Chief Executive Officer | Chief Executive Officer | 2016 – 2017 |
KE Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
SV Chief Executive Officer | Chief Executive Officer | 2019 – 2021 |
NC Chief Executive Officer | Chief Executive Officer | 2017 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2019 | |
| Board of Directors | 2026 | |
| Former (4) | ||
| Board of Directors | 2016 – 2021 | |
| Board of Directors | 2024 – 2026 | |
| Chairman | 2016 – 2019 | |
| Board of Directors | 2019 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2025 | |
| Individual | 100% | 100% | 2025 | |
| Individual | 100% | 100% | 2016 | |
| Individual | 100% | 100% | 2017 | |
| Individual | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Phillips-Medisize Holdings A/S 
Phillips-Medisize A/SBoard members of Phillips-Medisize Holdings A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Charles Sills | Chief Executive Officer | 0 companies |
| Cecilie Rørbye | Chief Executive Officer | 0 companies |
| Katrine Eggert Hammer | Chief Executive Officer | 0 companies |
| Søren Vestergård Jacobsen | Chief Executive Officer | 0 companies |
| Norman Charles Roegner III | Chief Executive Officer | 0 companies |
| Mikkel Baaring Lerche | Founder | 0 companies |
| Brett Alan Landrum | Board of Directors | 0 companies |
| David William Cole | Chairman | 0 companies |
| William Patrick Welch | Board of Directors | 0 companies |
| Sean David Rice | Board of Directors | 0 companies |
| Nitesh Gupta | Board of Directors | 0 companies |
| Matthew Jon Jennings | Chairman | 0 companies |
| Katherine Mary Dornan | Board of Directors | 0 companies |